Suppliers / Gracure Pharmaceuticals

Gracure Pharmaceuticals

United Arab Emirates 539 employees 2 duplicate records merged Updated 9 July 2026

Gracure Pharmaceuticals is a contract manufacturer based in United Arab Emirates. It appears in 61 regulatory filings across 4 regulators, without an active US DMF or CEP on file. Its filings concentrate with DAV (Vietnam), EFDA (ET) and MINSA (CR). Its GMP standing is certified by EMA and NAFDAC (NG). Customs aggregates show $31.9M of exports covering 1,416 molecules to 20 destinations in 2025.

0
active US DMFs
0
valid CEPs
3
registered plants
61
filings across 4 regulators
These figures were checked against the regulators' own files on 25 July 2026
EU GMP
1 of 1 confirmed
Sources: EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Registered plants

Site FDA FEI
Rajasthan, United Arab Emirates Not on file
Bhiwadi, India Not on file
Alwar, Nigeria Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
DAV (Vietnam) 47 None
EFDA (ET) 12 None
MINSA (CR) 1 None
ZAMRA (ZM) 1 None
EMA None 3
NAFDAC (NG) None 1

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $4.2M 13
2025 Not reported $31.9M 20
2024 Not reported $32.0M 21
2023 Not reported $26.1M 21

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Gracure Pharmaceuticals comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts